Establishes kratom, otherwise known as mitragyna speciosa korth, as a schedule I controlled substance.
Summary
Bill S07379 seeks to amend the public health law in New York by classifying kratom, scientifically known as mitragyna speciosa korth, as a Schedule I controlled substance. This classification implies that kratom will be subject to strict regulations similar to other substances deemed to have a high potential for abuse and no accepted medical use. The bill outlines the necessary amendments to the existing public health law to include kratom in the list of controlled substances, thereby restricting its sale, distribution, and possession within the state.
Impact
The impact of this bill on state laws is significant, as it will alter the legal status of kratom, making it illegal to possess, sell, or distribute. This change will affect various stakeholders, including vendors, users, and health professionals. The bill aims to address public health concerns related to the use of kratom, which has been associated with adverse health effects and potential addiction. By placing kratom on the controlled substances list, the state will enhance its ability to regulate and monitor its use.
Sentiment
The sentiment surrounding Bill S07379 appears to be mixed, with some support for the regulation of substances that pose health risks, while others express concern over the potential criminalization of users who rely on kratom for pain relief or other therapeutic purposes. Discussions in committee have highlighted the need for further research into kratom's effects and the implications of its prohibition.
Contention
Notable points of contention include the debate over the safety and efficacy of kratom as a substance for pain management and its potential for abuse. Proponents of the bill argue that kratom poses significant health risks and should be regulated, while opponents contend that banning it could negatively impact individuals who use it responsibly for therapeutic reasons. This division is evident among health professionals, users, and lawmakers.